durocitinib   Click here for help

GtoPdb Ligand ID: 14613

Synonyms: compound 95 [US20240383916]
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Durocitinib is the INN for a Janus kinase inhibitor with anti-inflammatory and immunosuppressant potential. Structure provided in WHO INN proposed list 135 (July 2026). The chemical structure is in fact claimed as an allosteric (pseudokinase JH2 domain) inhibitor of the TYK2 Janus kinase isoform, in patents held by Sudo Biosciences [1-2]. Sudo Biosciences have two TYK2 inhibitors in their declared development pipeline; SUDO-550, which is orally bioavailable and brain-penetrant, that proposed for the treatment of neuroinflammatory diseases, and SUDO-286 which is intended for topical application as a treatment for immune-mediated dermatologic conditions. Given the low logP value for this compound it is more likely to be SUDO-286 than SUDO-550, but we cannot be certain until the name-structure is formally disclosed.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 12
Hydrogen bond donors 3
Rotatable bonds 7
Topological polar surface area 138.51
Molecular weight 448.48
XLogP 2.16
No. Lipinski's rules broken 1

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@@]1([H])C2=NN(C)N=C2C3=CC=NC(=C3N1C)NC4=C(C(=O)NC([2H])([2H])[2H])N=NC(=C4)NC(=O)C5CC5
Isomeric SMILES N1=C(NC=2C=C(NC(C3CC3)=O)N=NC2C(=O)NC([2H])([2H])[2H])C=4N(C)[C@](C)([H])C5=NN(C)N=C5C4C=C1
InChI InChI=1S/C21H24N10O2/c1-10-15-16(29-31(4)28-15)12-7-8-23-19(18(12)30(10)3)24-13-9-14(25-20(32)11-5-6-11)26-27-17(13)21(33)22-2/h7-11H,5-6H2,1-4H3,(H,22,33)(H2,23,24,25,26,32)/t10-/m0/s1/i2D3
InChI Key ZLYHFSIQANXNOH-XBKOTWQMSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Classification Click here for help
Compound class Synthetic organic
IUPAC Name Click here for help
6-(cyclopropanecarbonylamino)-N-(trideuteriomethyl)-4-[[(4S)-2,4,5-trimethyl-4H-triazolo[4,5-c][1,7]naphthyridin-6-yl]amino]pyridazine-3-carboxamide
International Nonproprietary Names Click here for help
INN number INN
13640 durocitinib
Synonyms Click here for help
compound 95 [US20240383916]
Database Links Click here for help
CAS Registry No. 2821087-28-7 (source: WHO INN record)
GtoPdb PubChem SID 530846861
PubChem CID 164902821
Search Google for chemical match using the InChIKey ZLYHFSIQANXNOH-XBKOTWQMSA-N
Search Google for chemicals with the same backbone ZLYHFSIQANXNOH
Search PubMed clinical trials durocitinib
Search PubMed titles durocitinib
Search PubMed titles/abstracts durocitinib
UniChem Compound Search for chemical match using the InChIKey ZLYHFSIQANXNOH-XBKOTWQMSA-N
UniChem Connectivity Search for chemical match using the InChIKey ZLYHFSIQANXNOH-XBKOTWQMSA-N